Information de reference pour ce titreAccession Number: | 00006562-202005000-00015.
|
Author: | Sodhi, Mohit 1; Etminan, Mahyar *,1,2,3
|
Institution: | (1)Department of Ophthalmology and Visual Sciences Faculty of Medicine University of British Columbia Vancouver British Columbia Canada (2)Department of Medicine Faculty of Medicine University of British Columbia Vancouver British Columbia Canada (3)Department of Pharmacology and Therapeutics Faculty of Medicine University of British Columbia Vancouver British Columbia Canada
|
Title: | |
Source: | Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy. 40(5):487-488, May 2020.
|
References: | 1. Zakeri B, Wright GD. Chemical biology of tetracycline antibiotics. Biochem Cell Biol 2008;86(2):124-36.
2. Humar A, McGilvray I, Phillips MJ, Levy GA. Severe acute respiratory syndrome and the liver. Hepatology 2004;39:291-4.
3. Phillips JM, Gallagher T, Weiss SR. Neurovirulent murine coronavirus JHM.SD uses cellular zinc metalloproteases for virus entry and cell-cell fusion. J Virol 2017;91(8):e01564-16.
4. Rothan HA, Mohamed Z, Paydar M, Rahman NA, Yusof R. Inhibitory effect of doxycycline against dengue virus replication in vitro. Arch Virol 2014;159(4):711-8.
5. Sturtz FG. Antimurine retroviral effect of doxycycline. Methods Find Exp Clin Pharmacol 1998;20(8):643-7.
6. Henehan M, Montuno M, De Benedetto A. Doxycycline as an anti-inflammatory agent: updates in dermatology. J Eur Acad Dermatol Venereol 2017;31(11):1800-8.
7. Yoshikawa T, Hill T, Li K, Peters CJ, Tseng CT. Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J Virol 2009;83(7):3039-48.
8. Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy [published online ahead of print, 2020 Feb 4]. J Biol Regul Homeost Agents 2020;34(1). https://pubmed.ncbi.nlm.nih.gov/...- ouverture dans une nouvelle fenêtre.
9. Sandler C, Nurmi K, Lindstedt KA, et al. Chemically modified tetracyclines induce apoptosis in cultured mast cells. Int Immunopharmacol 2005;5(11):1611-21.
10. Sandler C, Ekokoski E, Lindstedt KA, et al. Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells: possible involvement of protein kinase C. Inflamm Res 2005;54(7):304-12.
11. Dutta K, Basu A. Use of minocycline in viral infections. Indian J Med Res 2011;133:467-70.
12. Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 2010;299(3):C539-48.
|
Language: | English.
|
Document Type: | LETTERS TO THE EDITOR.
|
Journal Subset: | Pharmacology.
|
ISSN: | 0277-0008
|
NLM Journal Code: | par, 8111305
|
DOI Number: | https://dx.doi.org/10.1002/phar....- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |